Richard Testar
9Patents
3h-index
6Co-inventors
42Inventor score
Filing activity: Sep 11, 2015 → Apr 3, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10183939B2 | Fused bicyclic (hetero)aromatic compounds useful for the treatment of cancers | Chemistry; Metallurgy | 36 | Active |
| US10047079B2 | N-pyridinyl acetamide derivatives as inhibitors of the Wnt signaling pathway | Chemistry; Metallurgy | 6 | Active |
| US10202375B2 | N-pyridinyl acetamide derivatives as Wnt signalling pathway inhibitors | Chemistry; Metallurgy | 5 | Active |
| US10793560B2 | N-pyridinyl acetamide derivatives as inhibitors of the WNT signaling pathway | Chemistry; Metallurgy | 2 | Active |
| US11643408B2 | N-pyridinyl acetamide derivatives as inhibitors of the WNT signaling pathway | Chemistry; Metallurgy | 1 | Active |
| US10793562B2 | N-pyridinyl acetamide derivatives as Wnt signalling pathway inhibitors | Chemistry; Metallurgy | 1 | Active |
| US11459326B2 | N-pyridinyl acetamide derivatives as Wnt signalling pathway inhibitors | Chemistry; Metallurgy | 0 | Active |
| USRE49361E1 | Fused bicyclic (hetero)aromatic compounds useful for the treatment of cancers | General | 0 | Active |
| US12202826B2 | N-pyridinyl acetamide derivatives as inhibitors of the Wnt signaling pathway | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.